Silo Pharma (NASDAQ: SILO) today announced favorable preclinical results for SP-26, its novel extended-release ketamine implant aimed at treating fib ...

Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE ...

Silo Pharma, Inc. (NASDAQ:SILO) on Wednesday released results for its preclinical study evaluating SP-26. SP-26 is a ketamine ...

Silo Pharma (NASDAQ: SILO) announced the filing of a patent application with the U.S. Patent and Trademark Office for SPC-14, a novel intranasal comp ...

A Sarasota biopharmaceutical company is applying for a patent for an Alzheimer’s drug. Silo Pharma, based on North Washington ...

H.C. Wainwright & Co. is acting as manager. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on dosing, data on a ketamine ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

MANILA, Philippines – The head of a local group of pharmaceutical firms has expressed confidence that US President Donald Trump’s new tariff policy will have minimal impact on their sector ...

The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S ...

Drugmakers' stocks in Europe and India slipped on Wednesday after U.S. President Donald Trump reiterated plans for a "major" tariff on all pharmaceutical imports and as "reciprocal" tariffs ...

Continuing his economic onslaught, US President Donald Trump said on Tuesday that Washington is planning to announce a "major" tariff on pharmaceutical imports soon. India's pharmaceuticals sector ...